NBIX NEUROCRINE BIOSCIENCES INC
Nasdaq · SEC CIK 914475 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $77.87M 26 sales by 15 insiders
- Filings on record
- 361 since 2021-07-29, latest 2026-09-15 17:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| Cooke Julie | CHRO | — | $5.77M |
| Gano Kyle | CEO, Dir | — | $4.87M |
| Lippoldt Darin | CLO | — | $4.20M |
| SHERWIN STEPHEN A | Dir | — | $4.13M |
| Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| Onyia Jude | CSO | — | $3.47M |
| RASTETTER WILLIAM H | Dir | — | $2.73M |
| POPS RICHARD F | Dir | — | $2.36M |
| LYONS GARY A | Dir | — | $2.29M |
Transactions 470
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-04 | 2025-01-31 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale+OE | $152.94 | -1,104 | 1,369 | -45% | -$168.8K |
| DM | 2025-02-04 | 2025-01-31+ | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $150.81 | -1,045 | 2,886 | -27% | -$157.6K |
| DM | 2025-02-04 | 2025-01-31+ | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $0.00 | +1,980 | 3,308 | +149% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | Lippoldt Darin | CLO | M - OptEx | $0.00 | +2,373 | 42.1K | +6% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $152.91 | -1,250 | 40.9K | -3% | -$191.1K |
| D | 2025-02-04 | 2025-01-31 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale+OE | $152.80 | -1,457 | 32.4K | -4% | -$222.6K |
| D | 2025-02-04 | 2025-01-31 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $0.00 | +2,769 | 33.8K | +9% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | ABERNETHY MATT | CFO | M - OptEx | $0.00 | +2,436 | 34.0K | +8% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | ABERNETHY MATT | CFO | S - Sale+OE | $152.87 | -1,283 | 32.7K | -4% | -$196.1K |
| D | 2025-02-04 | 2025-01-31 | NBIX | Cooke Julie | CHRO | M - OptEx | $0.00 | +1,740 | 19.9K | +10% | $0 |
| DM | 2025-02-04 | 2025-01-31 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $152.89 | -1,740 | 18.2K | -9% | -$266.0K |
| D | 2025-02-04 | 2025-01-31 | NBIX | GORMAN KEVIN CHARLES | Dir | S - Sale+OE | $152.92 | -2,707 | 517.0K | -0.5% | -$414.0K |
| D | 2025-02-04 | 2025-01-31 | NBIX | GORMAN KEVIN CHARLES | Dir | M - OptEx | $0.00 | +5,141 | 519.7K | +1.0% | $0 |
| D | 2025-02-04 | 2025-01-31 | NBIX | Onyia Jude | CSO | S - Sale+OE | $152.97 | -126 | 15.6K | -0.8% | -$19.3K |
| D | 2025-02-04 | 2025-01-31 | NBIX | Onyia Jude | CSO | M - OptEx | $0.00 | +238 | 15.7K | +2% | $0 |
| D | 2025-01-29 | 2025-01-27 | NBIX | GORMAN KEVIN CHARLES | Dir | S - Sale+OE | $149.46 | -146.1K | 514.6K | -22% | -$21.84M |
| D | 2025-01-29 | 2025-01-27 | NBIX | GORMAN KEVIN CHARLES | Dir | M - OptEx | $32.99 | +146.1K | 660.7K | +28% | +$4.82M |
| DM | 2025-01-17 | 2025-01-15 | NBIX | Gano Kyle | CEO, Dir | M - OptEx | $32.99 | +65.0K | 195.6K | +50% | +$2.14M |
| DM | 2025-01-17 | 2025-01-15 | NBIX | Gano Kyle | CEO, Dir | S - Sale+OE | $141.50 | -65.0K | 135.4K | -32% | -$9.20M |
| D | 2025-01-03 | 2024-12-31 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +272 | 2,779 | +11% | +$21.5K |
| D | 2025-01-03 | 2024-12-31 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $138.10 | -272 | 2,507 | -10% | -$37.6K |
| D | 2024-12-19 | 2024-12-17 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +1,091 | 3,598 | +44% | +$86.2K |
| D | 2024-12-19 | 2024-12-17 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $135.00 | -1,091 | 2,507 | -30% | -$147.3K |
| D | 2024-12-03 | 2024-11-29 | NBIX | Onyia Jude | CSO | S - Sale+OE | $126.29 | -2,331 | 15.4K | -13% | -$294.4K |
| D | 2024-12-03 | 2024-11-29 | NBIX | Onyia Jude | CSO | M - OptEx | $0.00 | +4,426 | 17.8K | +33% | $0 |
| DM | 2024-11-12 | 2024-11-08 | NBIX | ROBERTS EIRY | Chief Medical Off | M - OptEx | $81.67 | +7,345 | 30.1K | +32% | +$599.9K |
| 2024-11-07 | 2024-11-04 | NBIX | SHERWIN STEPHEN A | Dir | G - Gift | $0.00 | -2,000 | 24.5K | -8% | $0 | |
| 2024-10-07 | 2024-10-03 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $113.66 | -1,295 | 377 | -77% | -$147.2K | |
| 2024-09-17 | 2024-09-13 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $121.88 | -3,461 | 1,672 | -67% | -$421.8K | |
| 2024-08-16 | 2024-08-15 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale | $146.69 | -14.2K | 37.5K | -28% | -$2.09M | |
| D | 2024-08-15 | 2024-08-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $103.52 | +3,043 | 9,650 | +46% | +$315.0K |
| DM | 2024-08-15 | 2024-08-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $150.10 | -7,143 | 6,607 | -52% | -$1.07M |
| D | 2024-08-15 | 2024-08-13 | NBIX | LYONS GARY A | Dir | M - OptEx | $42.76 | +11.6K | 130.6K | +10% | +$494.7K |
| D | 2024-08-15 | 2024-08-13 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $150.43 | -11.6K | 119.0K | -9% | -$1.74M |
| D | 2024-08-15 | 2024-08-13 | NBIX | ABERNETHY MATT | CFO | M - OptEx | $73.60 | +14.1K | 45.6K | +45% | +$1.04M |
| D | 2024-08-15 | 2024-08-13 | NBIX | ABERNETHY MATT | CFO | S - Sale+OE | $150.38 | -14.1K | 31.5K | -31% | -$2.12M |
| D | 2024-08-08 | 2024-08-06 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +273 | 6,880 | +4% | +$21.6K |
| D | 2024-08-08 | 2024-08-06 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $147.70 | -273 | 6,607 | -4% | -$40.3K |
| D | 2024-08-05 | 2024-08-01 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $154.01 | -2,996 | 39.7K | -7% | -$461.4K |
| D | 2024-08-05 | 2024-08-01 | NBIX | Lippoldt Darin | CLO | M - OptEx | $79.02 | +2,996 | 42.7K | +8% | +$236.7K |
| D | 2024-08-05 | 2024-08-01 | NBIX | Cooke Julie | CHRO | M - OptEx | $61.82 | +12.6K | 30.8K | +69% | +$780.9K |
| D | 2024-08-05 | 2024-08-01 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $153.26 | -12.6K | 18.2K | -41% | -$1.94M |
| D | 2024-07-18 | 2024-07-16 | NBIX | ABERNETHY MATT | CFO | S - Sale+OE | $150.04 | -900 | 31.5K | -3% | -$135.0K |
| D | 2024-07-18 | 2024-07-16 | NBIX | ABERNETHY MATT | CFO | M - OptEx | $73.60 | +900 | 32.4K | +3% | +$66.2K |
| D | 2024-07-18 | 2024-07-16 | NBIX | Lippoldt Darin | CLO | M - OptEx | $79.02 | +7,004 | 46.7K | +18% | +$553.5K |
| D | 2024-07-18 | 2024-07-16 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $150.00 | -7,004 | 39.7K | -15% | -$1.05M |
| D | 2024-07-18 | 2024-07-16 | NBIX | LYONS GARY A | Dir | M - OptEx | $42.76 | +930 | 120.0K | +0.8% | +$39.8K |
| D | 2024-07-18 | 2024-07-16 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $150.03 | -930 | 119.0K | -0.8% | -$139.5K |
| DM | 2024-07-18 | 2024-07-16 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $103.52 | +1,957 | 9,064 | +28% | +$202.6K |
| DM | 2024-07-18 | 2024-07-16 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $150.03 | -2,857 | 7,507 | -28% | -$428.6K |
| D | 2024-07-18 | 2024-07-16 | NBIX | Cooke Julie | CHRO | M - OptEx | $61.82 | +900 | 19.1K | +5% | +$55.6K |
| D | 2024-07-18 | 2024-07-16 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $150.04 | -900 | 18.2K | -5% | -$135.0K |
| D | 2024-07-02 | 2024-07-01 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +272 | 7,779 | +4% | +$21.5K |
| D | 2024-07-02 | 2024-07-01 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $138.11 | -272 | 7,507 | -3% | -$37.6K |
| D | 2024-07-02 | 2024-07-01 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $140.19 | -10.0K | 18.2K | -35% | -$1.40M |
| D | 2024-07-02 | 2024-07-01 | NBIX | Cooke Julie | CHRO | M - OptEx | $61.82 | +10.0K | 28.2K | +55% | +$618.2K |
| D | 2024-06-04 | 2024-05-31 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +273 | 7,780 | +4% | +$21.6K |
| D | 2024-06-04 | 2024-05-31 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $136.55 | -273 | 7,507 | -4% | -$37.3K |
| DM | 2024-05-30 | 2024-05-29 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $44.68 | +40.0K | 41.5K | +2,660% | +$1.79M |
| DM | 2024-05-30 | 2024-05-29 | NBIX | SHERWIN STEPHEN A | Dir | S - Sale+OE | $133.46 | -40.0K | 26.5K | -60% | -$5.34M |
| D | 2024-05-21 | 2024-05-17 | NBIX | POPS RICHARD F | Dir | M - OptEx | $0.00 | +4,199 | 33.7K | +14% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $141.84 | -2,100 | 31.6K | -6% | -$297.9K |
| D | 2024-05-21 | 2024-05-17 | NBIX | LYONS GARY A | Dir | M - OptEx | $0.00 | +2,100 | 119.0K | +2% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | Mercier Johanna | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $0.00 | +4,199 | 26.5K | +19% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | Norwalk Leslie V | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | Norwalk Leslie V | Dir | S - Sale+OE | $141.82 | -1,106 | 994 | -53% | -$156.9K |
| D | 2024-05-21 | 2024-05-17 | NBIX | Sharp Shalini | Dir | S - Sale+OE | $141.90 | -1,106 | 994 | -53% | -$156.9K |
| D | 2024-05-21 | 2024-05-17 | NBIX | Sharp Shalini | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | MORROW GEORGE J | Dir | M - OptEx | $0.00 | +4,199 | 4,199 | New | $0 |
| DM | 2024-05-16 | 2024-05-14+ | NBIX | ABERNETHY MATT | CFO | S - Sale+OE | $137.95 | -30.0K | 31.5K | -49% | -$4.14M |
| DM | 2024-05-16 | 2024-05-14+ | NBIX | ABERNETHY MATT | CFO | M - OptEx | $73.60 | +30.0K | 46.5K | +182% | +$2.21M |
| D | 2024-05-16 | 2024-05-14 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $135.63 | -12.5K | 116.9K | -10% | -$1.70M |
| D | 2024-05-16 | 2024-05-14 | NBIX | LYONS GARY A | Dir | M - OptEx | $42.76 | +12.5K | 129.4K | +11% | +$534.5K |
| D | 2024-05-08 | 2024-05-06 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +273 | 7,780 | +4% | +$21.6K |
| D | 2024-05-08 | 2024-05-06 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $140.55 | -273 | 7,507 | -4% | -$38.4K |
| DM | 2024-04-17 | 2024-04-15 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $81.21 | +19.8K | 48.0K | +70% | +$1.61M |
| DM | 2024-04-17 | 2024-04-15 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $133.36 | -19.8K | 40.8K | -33% | -$2.64M |
| D | 2024-04-03 | 2024-04-01 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $137.30 | -272 | 7,507 | -3% | -$37.3K |
| D | 2024-04-03 | 2024-04-01 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +272 | 7,779 | +4% | +$21.5K |
| D | 2024-03-25 | 2024-03-21 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $145.06 | -5,000 | 7,507 | -40% | -$725.3K |
| D | 2024-03-25 | 2024-03-21 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $103.52 | +5,000 | 12.5K | +67% | +$517.6K |
| DM | 2024-03-15 | 2024-03-14 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $80.90 | +75.0K | 110.3K | +212% | +$6.07M |
| DM | 2024-03-15 | 2024-03-14 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $139.38 | -75.0K | 40.8K | -65% | -$10.45M |
| DM | 2024-03-15 | 2024-03-14 | NBIX | MORROW GEORGE J | Dir | M - OptEx | $39.79 | +40.0K | 20.0K | New | +$1.59M |
| DM | 2024-03-15 | 2024-03-14 | NBIX | MORROW GEORGE J | Dir | S - Sale+OE | $139.41 | -40.0K | 0 | -100% | -$5.58M |
| D | 2024-03-15 | 2024-03-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $140.14 | -3,000 | 7,507 | -29% | -$420.4K |
| D | 2024-03-15 | 2024-03-13 | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $106.02 | +3,000 | 10.5K | +40% | +$318.1K |
| D | 2024-03-15 | 2024-03-13 | NBIX | POPS RICHARD F | Dir | M - OptEx | $42.76 | +23.2K | 52.7K | +79% | +$992.0K |
| D | 2024-03-15 | 2024-03-13 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $140.33 | -23.2K | 29.5K | -44% | -$3.26M |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $106.02 | +2,000 | 7,707 | +35% | +$212.0K |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $140.03 | -2,000 | 7,507 | -21% | -$280.1K |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $140.05 | -1,800 | 29.5K | -6% | -$252.1K |
| DM | 2024-03-12 | 2024-03-08+ | NBIX | POPS RICHARD F | Dir | M - OptEx | $42.76 | +1,800 | 29.6K | +6% | +$77.0K |
| D | 2024-02-29 | 2024-02-27 | NBIX | Norwalk Leslie V | Dir | M - OptEx | $84.95 | +8,000 | 8,000 | New | +$679.6K |
| D | 2024-02-29 | 2024-02-27 | NBIX | Norwalk Leslie V | Dir | S - Sale+OE | $135.67 | -8,000 | 0 | -100% | -$1.09M |
| DM | 2024-02-29 | 2024-02-28+ | NBIX | Delaet Ingrid | Chief Regulatory Off | S - Sale+OE | $135.34 | -6,817 | 7,507 | -48% | -$922.6K |
| DM | 2024-02-29 | 2024-02-28+ | NBIX | Delaet Ingrid | Chief Regulatory Off | M - OptEx | $79.02 | +6,817 | 10.0K | +214% | +$538.7K |
| DM | 2024-02-29 | 2024-02-28 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $134.69 | -75.0K | 40.6K | -65% | -$10.10M |
| DM | 2024-02-29 | 2024-02-28 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $53.67 | +75.0K | 93.8K | +400% | +$4.03M |
Purchase Sale Sale after option exercise All abbreviations